Hepatitis B virus infection and metabolic syndrome: Fact or fiction?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 1, 2015, Pages 14-20

  Wang, Chia Chi ^a,b   Tseng, Tai Chung ^a,b   Kao, Jia Horng ^c  

^a Department of Gastroenterology and Hepatology Taipei Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation ^*  (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arteriosclerosis; Fatty liver; Hepatitis B virus; Insulin resistance; Lipid; Metabolic syndrome

Indexed keywords

LIPID;

ARTERIOSCLEROSIS; CHRONIC HEPATITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; FATTY LIVER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; CARCINOMA, HEPATOCELLULAR; CARDIOVASCULAR DISEASES; COMPLICATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; PREVALENCE;

CARCINOMA, HEPATOCELLULAR; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HEPATITIS B, CHRONIC; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; METABOLIC SYNDROME X; OBESITY; PREVALENCE;

EID: 84919595063     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12700     Document Type: Review

References (60)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2002; 2: 395-403.
2. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993; 262: 369-370.
3. Chen DS, Hsu NH, Sung JL etal. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987; 257: 2597-2603.
4. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 2006; 23: 469-480.
5. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol. Biomarkers Prev. 2002; 11: 385-391.
6. Chen CL, Yang HI, Yang WS etal. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-121.
7. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
8. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
9. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
10. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669.
11. Bugianesi E, Salamone F, Negro F. The interaction of metabolic factors with HCV infection: does it matter? J. Hepatol. 2012; 56 (Suppl. 1): S56-65.
12. Corey KE, Kane E, Munroe C, Barlow LL, Zheng H, Chung RT. Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology 2009; 50: 1030-1037.
13. Kim KH, Shin HJ, Kim K etal. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007; 132: 1955-1967.
14. Li WC, Lee YY, Chen IC etal. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. Liver Int. 2013; 33: 1194-1202.
15. Li X, Ren N, Ling W etal. Adiponectin and its receptors in chronic hepatitis B patients with metabolic syndrome in China. Hepatogastroenterology 2012; 59: 1735-1743.
16. Wong VW, Wong GL, Chu WC etal. Hepatitis B virus infection and fatty liver in the general population. J. Hepatol. 2012; 56: 533-540.
17. Jarčuška P, Janičko M, Kružliak P etal. Hepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study. Eur. J. Intern. Med. 2014; 25: 286-291.
18. Chung TH, Kim MC, Kim CS. Association between hepatitis B surface antigen seropositivity and metabolic syndrome. Korean J. Fam. Med. 2014; 35: 81-89.
19. Jinjuvadia R, Liangpunsakul S. Association between metabolic syndrome and its individual components with viral hepatitis B. Am. J. Med. Sci. 2014; 347: 23-27.
20. Jan CF, Chen CJ, Chiu YH etal. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int. J. Obes. (Lond) 2006; 30: 794-799.
21. Hashimoto E, Tokushige K, Farrell GC. Histological features of non-alcoholic fatty liver disease: what is important? J. Gastroenterol. Hepatol. 2012; 27: 5-7.
22. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J. Hepatol. 2009; 51: 433-445.
23. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-1978.
24. Cheng YL, Wang YJ, Kao WY etal. Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up. PLoS ONE 2013; 8: e72049.
25. Rastogi A, Sakhuja P, Kumar A etal. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J. Pathol. Microbiol. 2011; 54: 454-459.
26. Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J. Gastroenterol. Hepatol. 2011; 26: 1361-1367.
27. Xu QH, Jie YS, Shu X, Chen LB, Cao H, Li G. Relationship of fatty liver with HBV infection, hyperlipidemia and abnormal alanine aminotransferase. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009; 23: 141-143.
28. Minakari M, Molaei M, Shalmani HM etal. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors. Eur. J. Gastroenterol. Hepatol. 2009; 21: 512-516.
29. Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J. Gastroenterol. Hepatol. 2008; 23: 779-782.
30. Peng D, Han Y, Ding H, Wei L. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J. Gastroenterol. Hepatol. 2008; 23 (7 Pt 1): 1082-1088.
31. Shi JP, Fan JG, Wu R, Gao XQ, Zhang L, Wang H. Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2008; 16: 519-523.
32. Altlparmak E, Koklu S, Yalinkilic M etal. Viral and host causes of fatty liver in chronic hepatitis B. World J. Gastroenterol. 2005; 11: 3056-3059.
33. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim. Care 2013; 40: 195-211.
34. Grundy SM, Cleeman JI, Daniels SR etal.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
35. Chen JY, Wang JH, Lin CY etal. Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently. J. Gastroenterol. Hepatol. 2010; 25: 1763-1768.
36. Liu PT, Hwang AC, Chen JD. Combined effects of hepatitis B virus infection and elevated alanine aminotransferase levels on dyslipidemia. Metabolism 2013; 62: 220-225.
37. Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD. Chronic hepatitis B virus infection and dyslipidemia. J. Formos. Med. Assoc. 2004; 103: 286-291.
38. Hsu CS, Liu CH, Wang CC etal. Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J. Viral Hepat. 2012; 19: e48-57.
39. Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kao JH. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation. J. Gastroenterol. Hepatol. 2010; 25: 1420-1425.
40. Lee JG, Lee S, Kim YJ etal. Association of chronic viral hepatitis B with insulin resistance. World J. Gastroenterol. 2012; 18: 6120-6126.
41. Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J. Gastroenterol. 2011; 17: 5240-5245.
42. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J. Gastroenterol. Hepatol. 2002; 17: 677-681.
43. Ahmadieh H, Azar ST. Liver disease and diabetes: association, pathophysiology, and management. Diabetes Res. Clin. Pract. 2014; 104: 53-62.
44. Moritani M, Adachi K, Arima N etal. A study of arteriosclerosis in healthy subjects with HBV and HCV infection. J. Gastroenterol. 2005; 40: 1049-1053.
45. Yang KC, Chen MF, Su TC etal. Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese. Atherosclerosis 2007; 195: 392-397.
46. Amirzadegan A, Davoodi G, Boroumand MA, Darabyan S, Dehkordi MR, Goodarzynejad H. Association between hepatitis B surface antibody seropositivity and coronary artery disease. Indian J. Med. Sci. 2007; 61: 648-655.
47. Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD. Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J. Gastroenterol. 2005; 11: 1292-1296.
48. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J. Hepatol. 2007; 46: 1126-1132.
49. Wang Y, Li YY, Nie YQ, Zhou YJ, Cao CY, Xu L. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Exp. Ther. Med. 2013; 6: 77-84.
50. Chitturi S, Farrell GC, George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J. Gastroenterol. Hepatol. 2004; 19: 368-374.
51. Turati F, Talamini R, Pelucchi C etal. Metabolic syndrome and hepatocellular carcinoma risk. Br. J. Cancer 2013; 108: 222-228.
52. Zhao J, Zhao Y, Wang H, Gu X, Ji J, Gao C. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study. Nutr. J. 2011; 10: 49-56.
53. Yu MW, Shih WL, Lin CL etal. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J. Clin. Oncol. 2008; 26: 5576-5582.
54. Mena Á, Pedreira JD, Castro Á, López S, Vázquez P, Poveda E. Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers. J. Gastroenterol. Hepatol. 2014; 29: 173-178.
55. Wong GL, Chan HL, Yu Z etal. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B-a prospective cohort study with paired transient elastography examinations. Aliment. Pharmacol. Ther. 2014; 39: 883-893.
56. Wong GL, Wong VW, Choi PC etal. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009; 58: 111-117.
57. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 2011; 54: 463-471.
58. Huang YW, Wang TC, Lin SC etal. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study. Clin. Infect. Dis. 2013; 57: 1695-1702. [Epub ahead of print].
59. Lin YC, Hsiao ST, Chen JD. Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults. World J. Gastroenterol. 2007; 13: 1805-1810.
60. Bondini S, Kallman J, Wheeler A etal. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007; 27: 607-611.